Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Phase II trial begins for CDA-1 for C. difficile-associated diarrhea

Oct. 14, 2005

GenPat77 receives grant to advance CEACAM1 into clinical testing

Oct. 14, 2005

ISIS-3082 prevents postoperative ileus in vivo

Oct. 13, 2005

Promising preclinical data reported for IBD compound at Advitech

Oct. 11, 2005

UPF-680's positive effects on biliary function

Oct. 11, 2005

Angiotensin II type 1 receptor antagonism attenuates experimental colitis

Oct. 11, 2005

Clinical data support the use of entecavir in chronic hepatitis B

Oct. 7, 2005

A phase III study confirms the efficacy of lubiprostone in constipation

Oct. 7, 2005

Update on the effects and safety of cilansetron in IBS-D

Oct. 7, 2005

Recent Theravance patent discloses novel 5-HT4 receptor agonists for gastrointestinal disorders

Oct. 6, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
BIO 2026: Alternatives to funding orphan drugs
BioWorld
At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...